Dr. Donald Taylor

  • Net Health Systems – Co-founder, President & CEO
  • Strategic Healthcare Programs – Vice President, Business Development
  • IBM (formerly Vivisimo) – Senior Director, Life Sciences
  • ThermoFisher Scientific – Global Marketing Manager
  • Cellumen – Vice President, Marketing & Corporate Development
  • Pittsburgh Life Sciences Greenhouse – Executive in Residence (current)

  • B.S. Information & Decision Systems – Carnegie Mellon University
  • M.S. Bioengineering – University of Pittsburgh
  • M.B.A. – University of Pittsburgh
  • Ph.D. Bioengineering – University of Pittsburgh
  • Postdoctoral – Department of Pathology, School of Medicine, University of Pittsburgh


Dr. Taylor has more than 20 years of life sciences commercial development experience. Dr. Taylor began his career as Co-founder, President and CEO of Net Health Systems, Inc., a healthcare information technology company engaged in web-based disease state management (acquired in 2012). Don served as an Executive-in-Residence at the Pittsburgh Life Sciences Greenhouse (PLSG) focused on healthcare information technology and biotechnology.  Prior to the PLSG he served as the Vice President of Corporate Development for Cellumen, Inc., a biotools/informatics company, and the predecessor company Cernostics, Inc., a cancer molecular diagnostics company. Prior to Cellumen and Cernostics, Don was the Global Pharmaceutical and Biotechnology Market Segment Manager for Thermo Fisher Scientific, Inc., where he led product marketing campaigns across a sales team of more than 500 people and $400 million in revenue. Don was the Senior Director of Business Development for Vivisimo, Inc., (acquired by IBM in 2012) providing big data software to the pharmaceutical and biotech industries. Prior to Vivisimo, Don was the Vice President of Business Development for Strategic Healthcare Programs, LLC (SHP), a Frost & Sullivan award-winning healthcare information technology company.

Don received a B.S. in Information Systems from Carnegie Mellon University, an M.S. and Ph.D. in Bioengineering from the Swanson School of Engineering at the University of Pittsburgh, an MBA from the Katz Graduate School of Business at the University of Pittsburgh, and conducted postdoctoral research at the University of Pittsburgh School of Medicine in the Department of Pathology. Dr. Taylor’s research was in collaboration with Massachusetts Institute of Technology on computational and wet lab investigations of cancer metastasis, wound healing, and stem cell therapies.